Life Sciences & Healthcare
Life sciences and healthcare: AI inside the regulatory pathway
Life sciences and healthcare leaders are working through the collision of scientific breakthroughs, value-based care, and escalating cyber and cost pressures, all under intense regulatory and societal scrutiny.
Commercial and operational execution for life sciences
What we do
Motif Platforms supports life sciences companies on commercial and operational execution. We work with pharma, biotech, medtech, and healthcare businesses on the priorities that need senior hands and quick, careful movement.
Life sciences carries long timelines and hard constraints, from the regulatory pathway to the realities of launch. We work within them and bring the operating focus to keep high-priority initiatives moving.
Where we help
Common work includes commercial strategy and launch readiness, pricing and market access decisions, operational improvement, and the execution of major change programs. We bring specialist resources into the team as each engagement requires.
We work with mid-market and growth-stage life sciences companies across the New York area and nationally.
AI in practice
Where AI changes the work in life sciences
Launch and commercial
AI that segments prescribers and accounts and tells field teams where to focus at launch.
Medical and regulatory content
Drafting and review support for regulated documents, with evaluations that check accuracy before anything goes out.
Clinical and real-world data
Structuring clinical notes and real-world data so models and analysts can use them.
Operations
Automation for supply and quality work that frees time for science and care.
Key issues leaders are working through
Healthcare is changing quickly, and these challenges need attention now.
Trust and security
Patient trust and data security are now strategic assets, not "IT topics," as cyberattacks on providers, payers, and manufacturers rise.
Cost versus innovation
Cost and workforce constraints are forcing hard trade-offs between innovation, access, and experience.
M&A integration
M&A and partnerships are critical for pipeline and capability, yet integration failures slow trials, disrupt supply, and confuse patients and providers.
Strategic balance
Strategy must balance breakthrough science, new care models, and affordability, while payers and regulators change the rules mid game.
Transformation stalls
Transformation efforts stall in the "last mile" where clinicians, operations, and technology must work differently every day.
Results from our work
Differentiated diagnostic platform
Radiology Strategy
A private equity firm wanted to build a technology-differentiated diagnostic platform through radiology roll-up using AI and offshore capabilities.
Validated entry strategy
Entry into Telehealth
A pharmaceutical company wanted to enter telehealth and needed solid diligence and a value creation plan to test its assumptions.